Children's Hospital Physician Elected to Institute of Medicine; Katherine A. High, M.D., is expert in pediatric hematology and gene therapy

10/10/2007

PHILADELPHIA, Oct. 10 /PRNewswire-USNewswire/ -- A leading physician-scientist at The Children's Hospital of Philadelphia, Katherine A. High, M.D., has been elected to the Institute of Medicine. Dr. High has long been a leading researcher in hematology and gene therapy.

(Photo: http://www.newscom.com/cgi-bin/prnh/20071010/DCW020 )

The Institute of Medicine (IOM) today announced the election of 65 new members from throughout the United States, in recognition of their major
contributions to the advancement of medical sciences, health care and public health. Established in 1970 by the National Academy of Sciences, the IOM honors professional achievement in the health sciences and serves as a national resource for independent analysis and recommendations on issues related to medicine, biomedical sciences and health.

Current members of the Institute elect new members from a slate of candidates nominated for their professional achievement and commitment to service.

An internationally prominent hematologist and researcher, Katherine A.
High, M.D., is the director of the Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia. She is the William H. Bennett Professor of Pediatrics at the University of Pennsylvania School of Medicine, and a Howard Hughes Medical Institute investigator. She also is a past president of the American Society of Gene Therapy.

Dr. High's studies of the molecular biology of the bleeding disorder hemophilia led to clinical trials of gene therapy for hemophilia at The Children's Hospital of Philadelphia. She leads a National Institutes of Health-funded laboratory and has contributed scores of papers to the scientific literature.

After graduating from Harvard College and the University of North Carolina School of Medicine, Dr. High completed her residency at North Carolina Memorial Hospital, followed by a fellowship in hematology at Yale University School of Medicine. She was on the medical staff of Yale-New Haven Hospital, and then directed the Clinical Coagulation Laboratory at the University of North Carolina Hospitals before coming to The Children's Hospital of Philadelphia in 1992.

Dr. High is a resident of Merion, Pa.

The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment toproviding exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in
the country, ranking third in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 430-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.

Contact: Joey Marie McCool
Phone: (267)426-6070
McCool@email.chop.edu